Skip to main content
. 2022 Nov 9;2022:9233199. doi: 10.1155/2022/9233199

Table 2.

Baseline clinical characteristics and outcomes of lactate normalization and nonnormalization.

Lactate normalization (n = 293) Lactate nonnormalization (n = 97) P value
Age, years 46 (37-60) 46 (38-59) 0.895
Male, N (%) 191 (65.2) 68 (70.1) 0.374
Etiology 0.585
 Biliary, N (%) 122 (14.1) 36 (37.1)
 Alcohol, N (%) 25 (8.5) 6 (6.2)
 Hypertriglyceridemia, N (%) 127 (43.3) 46 (47.4)
 Idiopathic, N (%) 19 (6.5) 9 (9.3)
Mechanical assisted ventilation, N (%) 88 (30) 50 (51.5) <0.001
Sepsis, N (%) 22(7.5) 18(18.6) <0.001
ACS, N (%) 16 (5.5) 19 (19.6) <0.001
Persistent respiratory failure, N (%) 185 (63.1) 69 (71.1) 0.152
Persistent renal failure, N (%) 39 (13.3) 34 (35.1) <0.001
Continuous circulatory failure, N (%) 4 (1.4) 6 (6.2) 0.009
PMOF, N(%) 34 (11.6) 34 (35.1) <0.001
Infectious pancreatic necrosis, N (%) 66 (22.5) 30 (30.9) 0.096
Length of hospital stay, day 14 (9-23) 16 (11-33) 0.104
ICU days, day 6 (1-14) 9 (3-17) 0.030
In hospital mortality, N (%) 37 (12.6) 31 (33.0) <0.001

ACS: abdominal compartment syndrome; PMOF: persistent multiple organ failure; ICU: intensive care unit; N: number.